← Eichor
Study identifier: NCT06921395 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Phase IV Study to Evaluate the Efficacy and Safety of Fang Le Shu Compared to Guo Na Fen for Controlled Ovarian Stimulation in Infertile Women Undergoing in Vitro Fertilization-embryo Transfer (IVF-ET).

Condition: Female Infertility  ·  Sponsor: LG Chem

PhasePhase 4
Planned participants248
Who can joinFemale, 20 Years to 39 Years
Healthy volunteersNo

About this study

The aim of this randomized, open-label, active-controlled, parallel-group, multicenter, phase IV study is to assess the efficacy and safety of Fang Le Shu versus Guo Na Fen used for controlled ovarian stimulation in infertile women undergoing In Vitro Fertilization-Embryo Transfer.

This description comes directly from the study's public registry record.

Talk to the study team

Clinical Study Lead  ·  +82-2-6987-4147  ·  lgclinical@lgchem.com

Always discuss trial participation with your own doctor first.

Locations (1)

The first affiliated hospital of Zhengzhou UniversityZhengzhou, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06921395